PTH and hypoparathyroidism: The high degree of satisfaction with TransCon PTH and its reported efficacy for hypoparathyroidism symptom management among patients who received the drug during the phase 3 study suggest that TransCon PTH may be an important and effective new treatment option for patients with hypoparathyroidism.